Risk of Hospital-Acquired Acute Kidney Injury among Adult Opioid Analgesic Users : A Multicenter Real-World Data Analysis
© 2023 The Author(s). Published by S. Karger AG, Basel..
Introduction: Comprehensive data on the risk of hospital-acquired (HA) acute kidney injury (AKI) among adult users of opioid analgesics are lacking. This study aimed to systematically compare the risk of HA-AKI among the users of various opioid analgesics.
Methods: This multicenter, retrospective real-world study analyzed 255,265 adult hospitalized patients who received at least one prescription of opioid analgesic during the first 30 days of hospitalization. The primary outcome was the time from the first opioid analgesic prescription to HA-AKI occurrence. 12 subtypes of opioid analgesics were analyzed, including 9 for treating moderate-to-severe pain and 3 for mild-to-moderate pain. We examined the association between the exposure to each subtype of opioid analgesic and the risk of HA-AKI using Cox proportional hazards models, using the most commonly used opioid analgesic as the reference group.
Results: As compared to dezocine, the most commonly used opioid analgesic for treating moderate-to-severe pain, exposure to morphine, but not the other 7 types of opioid analgesics, was associated with a significantly increased risk of HA-AKI (adjusted hazard ratio: 1.56, 95% confidence interval: 1.40-1.78). The association was consistent in stratified analyses and in a propensity-matched cohort. There were no significant differences in the risk of HA-AKI among the opioid analgesic users with mild-to-moderate pain after adjusting for confounders.
Conclusion: The use of morphine was associated with an increased risk of HA-AKI in adult patients with moderate-to-severe pain. Opioid analgesics other than morphine should be chosen preferentially in adult patients with high risk of HA-AKI when treating moderate-to-severe pain.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Kidney diseases (Basel, Switzerland) - 9(2023), 6 vom: 10. Dez., Seite 517-528 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pi, Mingjing [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acute kidney injury |
|---|
| Anmerkungen: |
Date Revised 13.12.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1159/000533556 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365801720 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365801720 | ||
| 003 | DE-627 | ||
| 005 | 20231229123713.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000533556 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1227.xml |
| 035 | |a (DE-627)NLM365801720 | ||
| 035 | |a (NLM)38089444 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pi, Mingjing |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Risk of Hospital-Acquired Acute Kidney Injury among Adult Opioid Analgesic Users |b A Multicenter Real-World Data Analysis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Author(s). Published by S. Karger AG, Basel. | ||
| 520 | |a Introduction: Comprehensive data on the risk of hospital-acquired (HA) acute kidney injury (AKI) among adult users of opioid analgesics are lacking. This study aimed to systematically compare the risk of HA-AKI among the users of various opioid analgesics | ||
| 520 | |a Methods: This multicenter, retrospective real-world study analyzed 255,265 adult hospitalized patients who received at least one prescription of opioid analgesic during the first 30 days of hospitalization. The primary outcome was the time from the first opioid analgesic prescription to HA-AKI occurrence. 12 subtypes of opioid analgesics were analyzed, including 9 for treating moderate-to-severe pain and 3 for mild-to-moderate pain. We examined the association between the exposure to each subtype of opioid analgesic and the risk of HA-AKI using Cox proportional hazards models, using the most commonly used opioid analgesic as the reference group | ||
| 520 | |a Results: As compared to dezocine, the most commonly used opioid analgesic for treating moderate-to-severe pain, exposure to morphine, but not the other 7 types of opioid analgesics, was associated with a significantly increased risk of HA-AKI (adjusted hazard ratio: 1.56, 95% confidence interval: 1.40-1.78). The association was consistent in stratified analyses and in a propensity-matched cohort. There were no significant differences in the risk of HA-AKI among the opioid analgesic users with mild-to-moderate pain after adjusting for confounders | ||
| 520 | |a Conclusion: The use of morphine was associated with an increased risk of HA-AKI in adult patients with moderate-to-severe pain. Opioid analgesics other than morphine should be chosen preferentially in adult patients with high risk of HA-AKI when treating moderate-to-severe pain | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Acute kidney injury | |
| 650 | 4 | |a Dezocine | |
| 650 | 4 | |a Hospital-acquired acute kidney injury | |
| 650 | 4 | |a Morphine | |
| 650 | 4 | |a Opioid analgesics | |
| 700 | 1 | |a Nie, Sheng |e verfasserin |4 aut | |
| 700 | 1 | |a Su, Licong |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Yanqin |e verfasserin |4 aut | |
| 700 | 1 | |a Cao, Yue |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Peiyan |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Yuxin |e verfasserin |4 aut | |
| 700 | 1 | |a Zha, Yan |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Yongjun |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Hua |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Jiajun |e verfasserin |4 aut | |
| 700 | 1 | |a Kong, Yaozhong |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Guisen |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Huafeng |e verfasserin |4 aut | |
| 700 | 1 | |a Wan, Qijun |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Chunbo |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Bicheng |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Qiongqiong |e verfasserin |4 aut | |
| 700 | 1 | |a Su, Guobin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Yilun |e verfasserin |4 aut | |
| 700 | 1 | |a Weng, Jianping |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Gang |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Gong, Mengchun |e verfasserin |4 aut | |
| 700 | 1 | |a Hou, Fan Fan |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Xin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Kidney diseases (Basel, Switzerland) |d 2015 |g 9(2023), 6 vom: 10. Dez., Seite 517-528 |w (DE-627)NLM254642748 |x 2296-9381 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2023 |g number:6 |g day:10 |g month:12 |g pages:517-528 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1159/000533556 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2023 |e 6 |b 10 |c 12 |h 517-528 | ||